Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

Ms_P Oct. 26 at 12:38 AM

$LQDA What did I learn from visiting the empty parking lot today? United Therapeutics has indeed set up an additional office literally a stone’s throw away from Liquidia’s headquarters (in addition to having the giant GSK honeycomb building). Clearly they are trying to intimidate Liquidia with proximity and lawfare tactics that they would not try with a larger company. Unfortunately for UTHR, bullying and picking on the little guy doesn’t increase the legal soundness of their arguments (and may actually be counterproductive with some judges who don’t like having their time wasted).

0 · Reply

LiquidThetaLEAPS Oct. 24 at 9:23 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LQDA Current Share Price: $22.49 Contracts: $LQDA January 15, 2027 $22 Calls Scale in: $9.31- $11.38 Scale out: $14.49-$18.63 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

KeelinTime Oct. 24 at 6:47 PM

$LQDA

0 · Reply

ArtVand Oct. 24 at 5:47 PM

$LQDA Whoever here is good at interpreting stock price movement, please share your thoughts here today and in the coming days. One of these days, the judge will rule. (I'd really be watching at the close - I assume any decision would be released sometime between 4PM-5PM EST) I realize I can't beat the speed of the algos - but I'd like to buy some more (obviously if the ruling favors lqda). A favorable ruling will really boost lqda; much of which will immediately happen. But I still think there will be upside even after than initial boom. An unfavorable ruling? Well, I am sure stevemano will opine on that. You have to admire his consistency. One way or the other, this stock is going to be volatile.

0 · Reply

Ms_P Oct. 24 at 2:13 PM

$LQDA Was getting concerned about delay of the legal decision but I agree with people on X that it could be due to the judge making extra sure his summary precludes additional action by UTHR. Great summary of the litigation history/risks here: https://tinyurl.com/3a63dpbm

2 · Reply

stevemano Oct. 24 at 1:56 PM

$LQDA more and bigger misses a coming!

1 · Reply

SteelerJon Oct. 24 at 12:14 PM

$LQDA 😎🏦🏦

0 · Reply

dayfornight99 Oct. 23 at 4:49 PM

$LQDA I don't understand the price movement on this stock.

3 · Reply

sachrebleu Oct. 23 at 2:08 AM

$LQDA time is patience

0 · Reply

KeelinTime Oct. 23 at 1:27 AM

$LQDA

0 · Reply

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Aug 27, 2025, 8:30 AM EDT - 2 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 13, 2025, 2:51 PM EDT - 2 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 12, 2025, 2:25 PM EDT - 2 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 12:43 PM EDT - 2 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 6:30 AM EDT - 2 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 30, 2025, 10:40 AM EDT - 4 months ago

What Next For Liquidia After Launch?

Jun 23, 2025, 4:34 PM EDT - 4 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 2, 2025, 6:30 AM EDT - 5 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 11:08 AM EDT - 5 months ago

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 8:00 AM EDT - 5 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 23, 2025, 2:28 PM EDT - 5 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 12, 2025, 6:00 AM EDT - 5 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 10, 2025, 9:29 PM EDT - 6 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 6 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 5, 2025, 4:06 PM EDT - 6 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 2, 2025, 5:28 PM EDT - 6 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 6 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 30, 2025, 9:30 AM EDT - 6 months ago

Arquitos Capital's Largest Holdings For Q1 2025

Apr 1, 2025, 10:33 AM EDT - 7 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 7 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 7 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 11:56 AM EDT - 7 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 6:30 AM EDT - 7 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Nov 15, 2024, 10:20 AM EST - 1 year ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 17, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 16, 2024, 9:41 AM EDT - 1 year ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Ms_P Oct. 26 at 12:38 AM

0 · Reply

LiquidThetaLEAPS Oct. 24 at 9:23 PM

0 · Reply

KeelinTime Oct. 24 at 6:47 PM

$LQDA

0 · Reply

ArtVand Oct. 24 at 5:47 PM

0 · Reply

Ms_P Oct. 24 at 2:13 PM

2 · Reply

stevemano Oct. 24 at 1:56 PM

$LQDA more and bigger misses a coming!

1 · Reply

SteelerJon Oct. 24 at 12:14 PM

$LQDA 😎🏦🏦

0 · Reply

dayfornight99 Oct. 23 at 4:49 PM

$LQDA I don't understand the price movement on this stock.

3 · Reply

sachrebleu Oct. 23 at 2:08 AM

$LQDA time is patience

0 · Reply

KeelinTime Oct. 23 at 1:27 AM

$LQDA

0 · Reply

Gambaa Oct. 22 at 7:00 PM

$LQDA ludicrous

0 · Reply

heyupikachu1821 Oct. 22 at 6:50 PM

$LQDA good time to buy. RSI is showing oversold on just about every time frame. due to bounce back

1 · Reply

BullRun4 Oct. 22 at 11:46 AM

$LQDA

1 · Reply

KeelinTime Oct. 22 at 1:07 AM

$LQDA

0 · Reply

Gambaa Oct. 21 at 9:31 PM

$LQDA must be the most unloved company

2 · Reply

Ms_P Oct. 21 at 7:05 PM

$LQDA May be another buying opportunity tomorrow before the judge finally rules. Most seem to think Judge Andrews will rule in LQDAs favor. After which time UTHR will have to put their lawfare to rest (finally).

3 · Reply

Ms_P Oct. 21 at 5:24 PM

$LQDA Report on PAH from Needham (PT 36) Second CHEST presentation in less than 2 hours

0 · Reply

heyupikachu1821 Oct. 21 at 5:20 PM

$LQDA if we can get past $26, we should be getting back to peak. if not, likely back to the $22’s. not expecting either to happen today. but hoping we don’t get another strong rejection from $25 then again, I’ve been making money every time it ping pongs in this chop zone. I’d just like to lessen my monitoring of it and go long with my initial purchase

1 · Reply

stevemano Oct. 21 at 4:04 PM

$LQDA lol. More like fudge the numbers eh bucky?! what a complete tool bag!

0 · Reply

dFerrari Oct. 21 at 3:50 PM

$LQDA I wonder what Steve Mano is gonna post when FY 2026 has $4.00 EPS. I can crunch the numbers for you…

1 · Reply

SteelerJon Oct. 21 at 1:07 PM

$LQDA 😎🏦🏦

0 · Reply

MikeWazowski44 Oct. 21 at 12:13 PM

$GLXY $GRAB $LQDA 🎯 GRAB is next

0 · Reply

Market Cap	1.93B
Revenue (ttm)	14.00M
Net Income (ttm)	-130.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-931.36%
Debt to Equity Ratio	12.75

Volume	1,008,100
Avg Vol	2,516,402
Day's Range	N/A - N/A
Shares Out	86.09M
Stochastic %K	15%
Beta	0.15
Analysts	Strong Sell
Price Target	$36.89